NMDA receptor agonists and _______ are currently in use for the treatment of AD.

Question

Quizplus · Accepted Answer

Cholinesterase inhibitors are currently in use for the treatment of Alzheimer's disease (AD). NMDA receptor agonists have been tested in clinical trials for AD treatment but have not yet been approved by the FDA. Adenosine receptors and D₂ receptors do not have a significant role in AD pathology, and acetylcholine receptor agonists are similar to cholinesterase inhibitors in their mechanism of action and may be used in conjunction with them, but do not represent a separate class of AD medication.

NMDA Receptor Agonists and _______ Are Currently in Use for the Treatment